Search Results

You searched for : Hikma

	Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain Latest pharma news update... Nov 03
	Hikma strengthens US Injectables business through acquisition of Custopharm Latest pharma update... Sep 29
	Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
	Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time The antiviral drug, which helped shorten the hospital recovery time in a U.S. trial, has been at the forefront of the battle against the ... Aug 11
	Hikma receives FDA approval for the generic version of Vascepa Hikma receives FDA approval for Icosapent Ethyl capsules... May 25
	Hikma Announces the Launch of Propofol Injectable Emulsion, USP Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US ... May 12
	Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma ... Feb 28
7 Matching result(s) found!

-Advertisements-

Trending Now
	Puducherry Government's Noble Initiative: Empowering Underprivileged Students in Medical EducationSeptember 23, 2023
	Title: From Dialysis to Freedom: Aditi's Inspiring kidney Transplant StorySeptember 23, 2023
	Narayana Health Achieves Guinness World Record with 3,797 ECGs Conducted in a DaySeptember 23, 2023
	Beyond Spoken Words, The Beauty of Sign Language: Celebrating the International Day of Sign LanguageSeptember 23, 2023
	Dengue: Symptoms, Warnings & NS1 antigen TestSeptember 23, 2023
	EQUIPPP welcomes Mr. Guru R. Sowle as an AdvisorSeptember 23, 2023
	Exploring Patient Safety : Empowering patients , Ensuring safetySeptember 22, 2023
	Manipal Hospitals Expands Its Footprint: A Game-Changer for Healthcare in Eastern IndiaSeptember 22, 2023
	Empowering Palliative Care: Workshop Highlights from Pain Awareness Month 2023September 22, 2023
	Studying Alzheimer's 7 Stages on World Alzheimer's DaySeptember 21, 2023
	AIIMS Takes the Lead in Transforming Indian Healthcare with 'Ayushman Bhav'September 21, 2023
	New study finds stressful jobs may double heart disease risk in womenSeptember 21, 2023
	Global Women’s Health Innovation Conference 2023September 21, 2023
	Our favourite cheese might just be a delicious way to boost our brainpower: Japanese Study Reveals Surprising FindingsSeptember 20, 2023
	Our favourite cheese might just be a delicious way to boost our brainpower: Japanese Study Reveals Surprising FindingsSeptember 20, 2023
	September 20, 2023
	From Code to Care: How IT Firms Are Shaping India's HealthcareSeptember 20, 2023
	Music and Sleep: Finding the Right Tune for Restful NightsSeptember 20, 2023
	Addressing Child Mortality in Nandurbar: A Critical LookSeptember 20, 2023
	Assam's Battle Against Toxic Magnesium Carbonate in Pan Masala BrandsSeptember 20, 2023

Search Results

Hyloris announces FDA acceptance of new drug application for Maxigesic IV in post-operative pain

Hikma strengthens US Injectables business through acquisition of Custopharm

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time

Hikma receives FDA approval for the generic version of Vascepa

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Trending Now